Table 2.
Comparison of patients who were treated inpatient or outpatient*.
| Outpatient (n = 22), n (%) | Inpatient (n = 24), n (%) | P | |
|---|---|---|---|
| Male sex | 13 (59.1) | 14 (58.3) | 0.97 |
| Age, years | 65±9 | 65±11 | |
| BMI, kg/m2 | 28.9 ± 4.5 | 28.7 ± 4.2 | 0.87 |
| FVC (L) (IQR) | 2.2 (0.8) | 2.4 (0.79) | 0.61 |
| FVC,% | 77.1 ± 19.5 | 67.0 ± 26.2 | 0.20 |
| DLCO,% | 50±14 | 39±19 | 0.07 |
| DLCO/VA,% | 68±22 | 60±22 | 0.29 |
| 6 MWT (m) (IQR) | 320 (135) | 380 (150) | 0.96 |
| SPO2 (min) (IQR) | 91 (7) | 89 (4) | 0.21 |
| Fever | 8 (36.4) | 13 (54.2) | 0.02 |
| Dyspnea | 11 (50) | 16 (66.7) | <0.001 |
| Cough | 4 (18.2) | 13 (54.2) | <0.001 |
| Consolidaton | 1 (4.6) | 10 (41.7) | <0.001 |
| Systemic steroid use | 14 (63.6) | 18 (75) | 0.09 |
| Favipiravir | 11 (50) | 12 (50) | 0.60 |
| Antibiotic use | 6 (27.3) | 8 (33.3) | 0.431 |
| Comorbidity | 18 (81.8) | 18 (75) | 0.48 |
| LTOT | 2 (9.1) | 12 (26.1) | <0.001 |
BMI: Body mass index; MWT: minute walk test; LTOT: long term oxygen therapy *Data are mean (SD) based on N unless stated otherwise. Percentages are based on N unless stated otherwise.